KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Revenue Growth (5y) (2017 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.89%
Dec 31, 2025 3.70%
Sep 30, 2025 4.10%
Jun 30, 2025 8.15%
Mar 31, 2025 9.13%
Dec 31, 2024 11.65%
Sep 30, 2024 11.27%
Jun 30, 2024 11.87%
Mar 31, 2024 9.48%
Dec 31, 2023 11.48%
Sep 30, 2023 11.08%
Jun 30, 2023 10.87%
Mar 31, 2023 9.03%
Dec 31, 2022 14.33%
Sep 30, 2022 16.19%
Jun 30, 2022 16.00%
Mar 31, 2022 15.67%
Dec 31, 2021 16.98%
Sep 30, 2021 17.40%
Jun 30, 2021 16.69%
Mar 31, 2021 16.91%
Dec 31, 2020 16.71%
Sep 30, 2020 16.77%
Jun 30, 2020 149.88%
Mar 31, 2020 11.33%
Dec 31, 2019 9.81%
Sep 30, 2019 11.06%
Jun 30, 2019 10.88%
Mar 31, 2019 11.40%
Dec 31, 2018 10.20%
Sep 30, 2018 12.07%
Jun 30, 2018 12.02%
Mar 31, 2018 12.88%
Dec 31, 2017 8.25%
Sep 30, 2017 9.18%
Jun 30, 2017 9.10%
Mar 31, 2017 9.40%